flutamide and pd 0325901

flutamide has been researched along with pd 0325901 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chia, KM; Liu, J; Naderi, A	1

Other Studies

1 other study(ies) available for flutamide and pd 0325901

Article	Year
Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer. Breast cancer research : BCR, 2011, Apr-01, Volume: 13, Issue:2 Topics: Androgen Receptor Antagonists; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Female; Flutamide; Humans; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Receptor, ErbB-2; Receptors, Androgen; Receptors, Estrogen; Signal Transduction; Trastuzumab; Xenograft Model Antitumor Assays	2011

Article

Year

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.

Breast cancer research : BCR, 2011, Apr-01, Volume: 13, Issue:2

Topics: Androgen Receptor Antagonists; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Female; Flutamide; Humans; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Receptor, ErbB-2; Receptors, Androgen; Receptors, Estrogen; Signal Transduction; Trastuzumab; Xenograft Model Antitumor Assays

2011